Portal vein thrombosis in the district general hospital: Management and clinical outcomes

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 5, 2009, Pages 517-521

  Farmer, Adam D ^a   Saadeddin, Abid ^b   Bruckner Holt, Caroline E M ^c   Bateman, Jeffrey M ^d   Ahmed, Monz ^b   Syn, Wyn King ^e  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c RUSSELLS HALL HOSPITAL   (United Kingdom)

^d PRINCESS ROYAL HOSPITAL   (United Kingdom)

^e DUKE UNIVERSITY   (United States)

Author keywords

Aetiology; District general hospital; Liver disease; Outcome; Portal vein thrombosis; Presentation; Thrombophilia

Indexed keywords

WARFARIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS VARICES; FEMALE; GENERAL HOSPITAL; HEART ATRIUM FIBRILLATION; HUMAN; LIVER FAILURE; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SEPSIS; STOMACH VARICES; SURVIVAL RATE; THROMBOPHILIA; TREATMENT OUTCOME; ULTRASOUND; UNITED KINGDOM; UPPER GASTROINTESTINAL BLEEDING; VEIN LIGATION; VEIN THROMBOSIS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEMATOLOGIC TESTS; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 67651146407     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328318ed6b     Document Type: Article

References (23)

1. Barr RD, Ouna N, Bagshawe AF. Portal vein thrombosis in adults. S Afr Med J 1977; 51:629-631.
2. Rodriguez-Luna H, Vargas HE. Portal vein thrombosis. Curr Treat Options Gastroenterol 2007; 10:435-443.
3. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 2007; 7:34. (Pubitemid 47423635)
4. Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Clin Pract 2006; 3:505-515. (Pubitemid 44322762)
5. Rossi S, Ghittoni G, Ravetta V, Torello Viera F, Rosa L, Serassi M, et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur Radiol 2008; 18:1749-1756.
6. Lee HK, Park SJ, Yi BH, Yeon EK, Kim JH, Hong HS. Portal vein thrombosis: CT features. Abdom Imaging 2008; 33:72-79.
7. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000; 32:865-871. (Pubitemid 30262750)
8. Ogren M, Bergqvist D, Bjorck M, Acosta S, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23796 consecutive autopsies. World J Gastroenterol 2006; 12:2115-2119.
9. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002; 34:535-538. (Pubitemid 34711994)
10. Carvajal S, Zapata R, Bertin P, Miquel JF. Portal vein thrombosis associated with essential thrombocytosis. Clinical cases and review of the literature. Rev Med Chil 1996; 124:353-358.
11. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab 2007; 53:583-589. (Pubitemid 351166424)
12. De Stefano V, Fiorini A, Rossi E, Za T, Chiusolo P, Sica S, Leone G. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007; 5: 708-714. (Pubitemid 46563568)
13. P'ng S, Carnley B, Baker R, Kontorinis N, Cheng W. Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation. Clin Gastroenterol Hepatol 2008; 6:472-475.
14. Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008; 111:4922-4929.
15. Von Bertele MJ. Late presentation of portal vein thrombosis as a complication of appendicitis. J R Army Med Corps 1993; 139:135-136.
16. Al-Jahdali H, Pon C, Thompson WG, Matzinger FR. Non-fatal portal pyaemia complicating Crohn's disease of the terminal ileum. Gut 1994; 35:560-561. (Pubitemid 24131258)
17. El-Matary W, Jaffray B, Scott J, Hodges S. Portal pyaemia as a presenting feature of paediatric crohn disease. J Pediatr Gastroenterol Nutr 2006; 43:260-262. (Pubitemid 44180516)
18. Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol 2007; 13:2535-2540. (Pubitemid 46938822)
19. Vleggaar FP, van Buuren HR, Schalm SW. Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population. Eur J Gastroenterol Hepatol 1998; 10:81-85.
20. Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 2005; 21:1-9.
21. Schafer C, Zundler J, Bode JC. Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature. Eur J Gastroenterol Hepatol 2000; 12:1141-1145. (Pubitemid 30786473)
22. Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006; 23:767-775. (Pubitemid 43344596)
23. Yang MT, Chen HS, Lee HC, Lin CL. Risk factors and survival of early bleeding after esophageal variceal ligation. Hepatogastroenterology 2007; 54:1705-1709. (Pubitemid 350068459)